HIGHLIGHTS
- who: Manuela Spadea from the Margherita Childrenu2019s Hospital, Turin, Italy University of Torino, Turin, Italy have published the research: Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment, in the Journal: (JOURNAL)
- what: IMCs arising in the post-HSCT setting represent a rare but potentially life-threatening complication.
- future: Considering the limited information on these variables further studies are needed for a thorough exploration of the interconnection of T_cell- and B cell-mediated pathomechanisms. Studies possibly perspective or even better randomized controlled trials are needed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.